AID-668-RFI-24-AHEC-FOLLOW-ON: USAID/South Sudan Care and Treatment Activity
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of South Sudan (USAID)-Juba notices from 2024.
South Sudan (USAID)-Juba offered grants of up to $30.0 million (at least $5.0 million) to any type of organization. It expected to make one award. Applications closed on May 14, 2024.
From the official notice on Grants.gov, last changed April 25, 2024. Checked November 7, 2026.
- Award ceiling$30.0 million
- Award floor$5.0 million
- Expected awards1
- Cost sharingNot required
- Funding typeOther
Key dates
| Posted | April 25, 2024 |
|---|---|
| Deadline | May 14, 2024 |
| Archived by Grants.gov | June 13, 2024 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $30.0 million per award.
- Most of the program's money (54% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
Dear Interested Parties: Pursuant to FAR 52.215-3 Request for Information (Oct. 1997), the United States Government, represented by The United States Agency for International Development (USAID) South Sudan Mission, is issuing the subject Request for Information (RFI) to all interested public and private entities on critical areas to support the delivery of integrated HIV care and treatment services for general and key populations including other disadvantaged populations such as people with disability and migrants. The Purposes of the care and treatment activity are: Improve equitable access to and use of quality comprehensive HIV prevention, testing, care, and treatment services for all South Sudanese. Provide quality comprehensive services for key populations at the current locations and expand as needed. Develop local partner capacity and prepare local partners to manage direct awards. This RFI is open for comments from any local Civil Society Organization (CSO), South Sudanese Organization, US, or non-US. Organization. This is an RFI, not a Request for Application (RFA). Do not submit any applications or proposals at this time; only the information requested per Attachment 1- RFI Questions for respondents and submission instructions- and all responses will be treated confidentially. Responses to this RFI may be used to help determine critical areas to support the delivery of integrated HIV care and treatment services for general and key populations, including other disadvantaged populations such as people with disability and migrants. USAID may revise the structure and concept of the activity based on the comments received, but it is not obligated to do so. All comments must be submitted electronically, with the subject of "RFI: USAID/South Sudan Care and Treatment Activity," no later than the date and time stated above. Please note: This is NOT a solicitation. This RFI is issued solely to gather information and innovative ideas for new design and planning purposes. This RFI does not constitute a Request for Applications (RFA), Request for Proposal (RFP), Notice of Funding Opportunity (NOFO), or a commitment to issue an RFA/RFP/NOFO in the future. USAID may release a full solicitation later through the US Government portal at beta.sam.gov or www.grants.gov.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is AID-668-RFI-24-AHEC-FOLLOW-ON still open?
No. It closed on May 14, 2024.
Who can apply for USAID/South Sudan Care and Treatment Activity?
South Sudan (USAID)-Juba accepted applications from any type of organization.
What is the deadline for USAID/South Sudan Care and Treatment Activity?
Closed May 14, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $30.0 million each.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)